ArticleToxicology reports2025

Gossypol enhances ponatinib's cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT/LC3II/p62, and Bcl2/caspase-3 pathways.

Hadeel H Elkattan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.